Because we detected an increase in papilloma incidence in IL-4Rα−/− compared to IL-4−/− mice (Fig. 3), we reasoned that IL-13 as the second ligand for IL-4Rα might have been responsible for this difference. This evidence concerns the gene IL4 and papilloma.